Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael E Salacz

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Palliative Medicine|July 4, 2006
Megestrol acetate for cancer anorexia/cachexia #100Michael E Salacz
Journal of Palliative Medicine|January 22, 2005
Controlled sedation for refractory suffering: part IMichael E Salacz, David E Weissman
Journal of Palliative Medicine|February 25, 2005
Controlled sedation for refractory suffering: part IIMichael E Salacz, David E Weissman
Journal of Palliative Medicine|February 15, 2007
Management of thrombocytopenia in bone marrow failure: a reviewMichael E Salacz, Michael W Lankiewicz, David E Weissman
Missouri Medicine|September 13, 2011
Glioblastoma. Part II: Future directionsMichael E Salacz, Kenneth R Watson, David A Schomas
Missouri Medicine|July 9, 2011
Glioblastoma: Part I. Current state of affairsMichael E Salacz, Kenneth R Watson, David A Schomas
Surgical Neurology International|November 10, 2017
Malignant glioma-primitive neuroectodermal tumor recurring as PNET-like only subdural collection: Case reportAnthony M Alvarado, Michael E Salacz, Roukoz B Chamoun
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 24, 2018
Hydration, methylene blue, and thiamine as a prevention regimen for ifosfamide-induced encephalopathyEyad Z Gharaibeh, Mohammad Telfah, Benjamin C Powers, et al.
Medical Oncology (Northwood, London, England)|May 1, 2016
"No patient left behind": an alternative to "the War on Cancer" metaphorBryan T Oronsky, Corey A Carter, Arnold L Oronsky, et al.
Oncotargets and Therapy|May 14, 2016
Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ RegimenMichael E Salacz, Richard E Kast, Najmaldin Saki, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Palliative Medicine|July 4, 2006
Megestrol acetate for cancer anorexia/cachexia #100Michael E Salacz
Journal of Palliative Medicine|January 22, 2005
Controlled sedation for refractory suffering: part IMichael E Salacz, David E Weissman
Journal of Palliative Medicine|February 25, 2005
Controlled sedation for refractory suffering: part IIMichael E Salacz, David E Weissman
Journal of Palliative Medicine|February 15, 2007
Management of thrombocytopenia in bone marrow failure: a reviewMichael E Salacz, Michael W Lankiewicz, David E Weissman
Missouri Medicine|September 13, 2011
Glioblastoma. Part II: Future directionsMichael E Salacz, Kenneth R Watson, David A Schomas
Missouri Medicine|July 9, 2011
Glioblastoma: Part I. Current state of affairsMichael E Salacz, Kenneth R Watson, David A Schomas
Surgical Neurology International|November 10, 2017
Malignant glioma-primitive neuroectodermal tumor recurring as PNET-like only subdural collection: Case reportAnthony M Alvarado, Michael E Salacz, Roukoz B Chamoun
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 24, 2018
Hydration, methylene blue, and thiamine as a prevention regimen for ifosfamide-induced encephalopathyEyad Z Gharaibeh, Mohammad Telfah, Benjamin C Powers, et al.
Medical Oncology (Northwood, London, England)|May 1, 2016
"No patient left behind": an alternative to "the War on Cancer" metaphorBryan T Oronsky, Corey A Carter, Arnold L Oronsky, et al.
Oncotargets and Therapy|May 14, 2016
Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ RegimenMichael E Salacz, Richard E Kast, Najmaldin Saki, et al.
Pageof 2